Quantcast

Shreis Scalene Sciences gets FDA ‘breakthrough’ designation

A Gaithersburg firm will likely get a prioritized review at for its cancer treatment device at the Food and Drug Administration under a program for medical devices that provide more effective treatment or diagnosis of serious diseases or conditions.

To purchase a reprint of this article, contact reprints@thedailyrecord.com.

Leave a Reply

Your email address will not be published. Required fields are marked *

*